Guideline Atlas

Bipolar disorder

Also known as: bipolar I · bipolar II · mania

Free to read — no account needed. Sign in only to bookmark this disease and track your study progress.

United StatesAPA

No APA guideline indexed for this condition yet.

Every entry is added by hand and cited to the issuing society, so a gap here means we have not verified one — not that none exists. Know the right one? Tell us.

EuropeEPA/NICE
Current

Bipolar disorder: assessment and management

NICE (UK) · 2014 · CG185

UK national guidance on recognising, assessing and managing bipolar disorder in children, young people and adults, spanning bipolar I, bipolar II, mixed affective and rapid-cycling presentations. Originally issued in 2014 and revised since; the most recent revision (September 2025) incorporated updated medicines-regulator safety advice on valproate use in men.

  • Covers all age groups, including children and young people, not adults only. source
  • Most recently updated on 2 September 2025 to reflect MHRA safety guidance on valproate in men. source

US vs EU key differences

No curated US/EU comparison yet for this disease.

What changed recently

  1. EUCG38 (2006)CG1852014-09-24

    CG185 updates every section of the 2006 CG38 guideline, and following a 2011 network meta-analysis narrows first-line treatment of acute mania to antipsychotics such as haloperidol, olanzapine, quetiapine or risperidone, demoting the wider range of options including valproate that CG38 had listed alongside them. It also bars valproate in girls and women of childbearing potential and keeps the prohibition on antidepressant monotherapy, requiring an antipsychotic if mania or hypomania emerges on an antidepressant.

    source ↗curation confidence 90%

See the full update feed for changes across every system.